NCT02936102 2025-11-14A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.NovartisPhase 1 Terminated154 enrolled
NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled